At a glance
ClinicalIndex Comparison RecordN/ACompleted· 96 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Circulating microRNA Signatures in Primary Hyperparathyroidism
In Brief
An observational study for Primary Hyperparathyroidism and Osteoporosis, Postmenopausal. Completed, enrolled 96 participants across 1 site.
Detailed Summary
The goal of this study is to: 1. Analyze the expression levels of circulating (serum) miRNAs in primary hyperparathyroidism patients with and without osteoporosis, and patients with osteoporosis undergoing thyroidectomy, and to correlate with clinical markers of bone remodeling including biochemical and radiologic studies. 2. To evaluate serum miRNA levels after treatment with parathyroidectomy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartSep 2018
First PostedApr 2019
Primary CompletionJul 2024
TodayJul 2026
First PostedApr 30, 2019
Enrollment StartSep 7, 2018
Primary CompletionJul 1, 2024
TodayJul 2, 2026
Enrollment to primary: 5.8 yearsPosted 7.2 years ago